Pediatric Cervical Lymphadenopathy

Michael S. Weinstock; Neha A. Patel; Lee P. Smith

doi:10.1542/pir.2017-0249

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Download PDF

Michael S. Weinstock, MD*,^†
Neha A. Patel, MD*
Lee P. Smith, MD*

^*Cohen Children’s Medical Center, Hofstra Northwell School of Medicine, New Hyde Park, NY
^†Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

AUTHOR DISCLOSURE
Drs Weinstock, Patel, and Smith have disclosed no financial relationships relevant to this article. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device.

Abstract

Cervical lymphadenopathy affects as many as 90% of children aged 4 to 8 years. With so many children presenting to doctors' offices and emergency departments, a systematic approach to diagnosis and evaluation must be considered. In the following review, we aim to provide the pediatric clinician with a general framework for an appropriate history and physical examination, while giving guidance on initial diagnostic laboratory testing, imaging, and potential need for biopsy. The most common cause of cervical lymphadenopathy in the pediatric population is reactivity to known and unknown viral agents. The second most common cause includes bacterial infections ranging from aerobic to anaerobic to mycobacterial infections. Malignancies are the most concerning cause of cervical lymphadenopathy.

The explosion in the use of ultrasonography as a nonradiating imaging modality in the pediatric population has changed the diagnostic algorithm for many clinicians. We aim to provide some clarity on the utility and shortcomings of the imaging modalities available, including ultrasonography, computed tomography, and magnetic resonance imaging.